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Abstract
Background: There are numerous examples of laboratory animals that were inadvertently exposed to endocrine
disrupting chemicals (EDCs) during the process of conducting experiments. Controlling contaminations in the
laboratory is challenging, especially when their source is unknown. Unfortunately, EDC contaminations can interfere
with the interpretation of data during toxicological evaluations. We propose that the male CD-1 mouse mammary
gland is a sensitive bioassay to evaluate the inadvertent contamination of animal colonies.
Methods: We evaluated mammary glands collected from two CD-1 mouse populations with distinct environmental
histories. Population 1 was born and raised in a commercial laboratory with unknown EDC exposures; Population 2
was the second generation raised in an animal facility with limited exposures to xenoestrogens from caging, feed,
etc. Mammary glands were collected from all animals and evaluated using morphometric techniques to quantify
morphological characteristics of the mammary gland.
Results: Population 1 (with suspected history of environmental chemical exposure) and Population 2 (with known
limited history of xenoestrogen exposure) were morphologically distinguishable in adult males, prepubertal females,
and pubertal females. Mammary glands from males raised in the commercial animal facility were significantly more
developed, with larger ductal trees and more branching points. The appearance of these mammary glands was
consistent with prior reports of male mice exposed to low doses of bisphenol A (BPA) during early development. In
females, the two populations were morphologically distinct at both prepuberty and puberty, with the most striking
differences observed in the number, size, and density of terminal end buds, e.g. highly proliferative structures found
in the developing mammary gland.
Conclusions: Collectively, these results suggest that the mouse mammary gland has the potential to be used as a
sentinel organ to evaluate and distinguish animal colonies raised in different environmental conditions including
potential EDC exposures. Our findings could help researchers that wish to perform a posteriori evaluations to
determine whether inadvertent contamination with xenoestrogens (and potentially other EDCs) has occurred in
their animal colonies, especially after new materials (feed, caging, water bottles) have been introduced. Finally, our
results challenge the relatively common practice of using historical controls in toxicological experiments.
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Background
Endocrine disrupting chemicals (EDCs) are compounds,
or mixtures of compounds, that interfere with hormone
actions by altering hormone synthesis, secretion, binding,
metabolism, or elimination [1, 2]. Scientists that study
EDCs in controlled laboratory experiments must take
concerted efforts to control contaminations from environ-
mental chemicals that could interfere with the assays be-
ing conducted and/or the endpoints being evaluated [3, 4].
These contaminations can be introduced by standard
laboratory consumables (disposable plastics, storage con-
tainers), disinfectants, laboratory equipment, and other
sources. In vitro assays designed to examine the role of
estrogens in breast cell proliferation were some of the first
studies to show that xenoestrogens can leach from com-
mercially available plastics [5, 6]. Further, studies in mice
that were originally intended to evaluate age-dependent
changes in ovarian function and the timing of pubertal
onset were disrupted by the unanticipated leaching of es-
trogenic chemicals from animals’ caging materials [7–10].
Experiments using laboratory animals must consider
a number of different potential sources of EDCs includ-
ing caging materials, water bottles (or tubing to deliver
water directly to the cage), bedding, enrichment mate-
rials, food, water, and even the air in the animal facility
[3, 11, 12]. A failure to rule out contamination can
make it difficult, or impossible, to draw accurate con-
clusions about the endocrine disrupting properties of
test chemicals. For example, if an experimenter wants
to evaluate whether a test chemical displays estrogenic
properties but all animals (including the unexposed nega-
tive controls) are inadvertently exposed to a xenoestrogen
from the environment, the treated animals may appear to
be non-responsive due to maximal stimulation of all
animals [13, 14].
Significant efforts have been invested to identify the
most sensitive endpoints to reveal the effects of EDCs
[15, 16]. Whereas traditional endpoints of toxicity (e.g.
significant loss of body weight, altered organ weight) are
typically used to evaluate chemicals for regulatory pur-
poses, numerous studies have demonstrated that the
endpoints evaluated in test guidelines are not sufficiently
sensitive to predict the effects of chemicals on humans,
particularly when exposures occur during vulnerable pe-
riods of development [17–19]. Studies that have directly
compared the effects of traditional guideline endpoints
with non-guideline endpoints are relatively rare [20], but
a large volume of data suggests that non-guideline end-
points can identify adverse effects of EDCs at doses far
below those that alter organ weight [21–23].
Our own work, and work from multiple other laborator-
ies, has shown that the rodent mammary gland is sensitive
to EDCs, especially when exposures occur during critical
windows of development [24–28]. We recently showed
that male CD-1 mice exposed to bisphenol A (BPA), a
well-known xenoestrogen, during the perinatal period de-
velop larger and more elaborated mammary epithelial
trees in adulthood [29]. These findings were particularly
interesting because male mice do not have nipples, leading
some researchers to conclude that they do not retain any
epithelial tissues [24]. The male CD-1 mouse mammary
gland may in fact be a sensitive bioassay that could be
used to evaluate novel compounds as well as evaluate the
potential for inadvertent contamination of animal popula-
tions with xenoestrogens, and perhaps compounds with
other endocrine disrupting properties [30, 31].
While conducting controlled laboratory experiments,
we have collected mammary glands from adult male
CD-1 mice that were born and raised in a commercial
laboratory. We noted that the epithelial trees in these
males were much larger and more developed than what
we previously reported for ‘control’ adult male mice;
rather, these males had mammary tissues that more
closely resembled animals developmentally exposed to
BPA [29]. Based on those observations, we asked if the
morphology of the mouse mammary gland can be used
to distinguish colonies of mice raised in different envi-
ronments including groups that may have experienced
EDC exposures. Here, we report the results of our evalu-
ations of two populations of mice: CD-1 mice ordered
from commercial laboratories, and CD-1 mice raised in
our animal facility for two generations under controlled
conditions with limited environmental chemical exposures
(e.g. exposures that were minimized wherever possible).
We find that these populations are distinguishable, with
the most striking differences in the adult male mammary
glands, suggesting this may be an appropriate sentinel
organ to evaluate an animal’s prior environmental expos-
ure to xenoestrogens and other EDCs.
Methods
Animals
Two populations of animals were evaluated in this study.
Population 1: CD-1 mice were ordered from a commer-
cial supplier (Charles River Laboratories, Raleigh, NC) in
adulthood (males, approximately 8 weeks of age) or at
postnatal day (PND) 22 (females, prepubertal) or PND32
(females, pubertal). Upon arrival, these animals (referred
to in the text as CRL animals) were group housed (typic-
ally 4 animals per cage) in polysulfone cages. Animals
were provided a low phytoestrogen feed (Harlan Teklad
2018) which has previously been shown to have estro-
genic activity in the low femtomolar range [32] and tap
water in glass bottles. CRL animals were housed under
these conditions for 2 to 3 weeks (adult males), 2 days
(prepubertal females) or 3 days (pubertal females). The
males were also used as breeders for other experiments.
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Population 2
Timed pregnant female CD-1 mice (pregnancy day 4–5)
were ordered from Charles River Laboratories and
housed according to the details provided above for
Population 1. These dams were allowed to deliver natur-
ally, and their litters (the F1 generation) were culled to
10 pups on PND1. Litters were weaned on PND21, the
female F1 offspring were group housed with up to 2 lit-
termates and raised to adulthood (approx. week 8). One
F1 female from each litter was mated to a control male
(ordered from Charles River Laboratories), and these fe-
males were also allowed to deliver naturally. Litters were
culled and weaned in the same manner as the previous
generation. The F2 offspring were continuously housed
under controlled conditions until they reached the same
ages as in Population 1. These animals will be referred
to throughout the text as F2 animals.
All animals were maintained in temperature and light
controlled (12 h light, 12 h dark, lights on at 0800 h) condi-
tions at the University of Massachusetts, Amherst Central
Animal Facility. All experimental procedures were ap-
proved by the University of Massachusetts Institutional
Animal Care and Use Committee (protocol 2014–0055).
Necropsies and dissections
At all ages (PND24, PND35, and adulthood), mice were
killed via CO2 inhalation followed by decapitation. Blood
was collected from all animals. The right fourth inguinal
mammary gland was isolated using standard dissection
methods, spread on a positively charged clear slide
(Fisher, Waltham MA), and fixed overnight in neutral
buffered formalin (Fisher) at room temperature.
Carmine alum whole mount processing/staining
Following fixation, whole mount mammary glands were
washed, dehydrated through an alcohol series and defat-
ted with toluene (Sigma-Aldrich, St. Louis MO). The
glands were then stained overnight with carmine alum
(Sigma-Aldrich), dehydrated through a series of alcohols
and xylene, and then placed in k-pax heat-sealed bags
(Fisher) with methyl salicylate (Fisher) to preserve them.
Mammary gland morphometrics
Whole mounts mammary glands were viewed and imaged
using a Zeiss Axio Imager dissection microscope and Zeiss
high-resolution color camera (Carl Zeiss, Oberkochen,
Germany). Zeiss ZEN Pro software was used for morpho-
metric analysis using methods developed previously
[29, 33]. Briefly, in females at both ages, specific mea-
surements were quantified including the area sub-
tended by the ducts (ductal area), the growth of the
longest duct from the center of the lymph node (ductal
extension), the total number of terminal end buds
(TEBs, defined as bulb-shaped structures ≥0.03 mm2),
and area of TEBs. Ductal density was evaluated using
the threshold tool to compare intensity of mammary
epithelium within 1.5 cm2 areas in the nipple and
lateral to the lymph node, or across the entire ductal
tree. In males, endpoints that were measured included
ductal area and number of branching points. TEBs were
never observed in adult males.
Enzyme Linked Immunosorbent Assay (ELISA)
Serum was isolated from blood samples collected from
all animals at the time of necropsy. A commercially
available kit (Calbiotech, Cat# ES180S-100) was used to
quantify 17β-estradiol levels in these serum samples.
The absorbance of the samples was measured at 450 nm
using a SpectroMax plate reader (Molecular Devices,
Sunnyvale CA). The limit of detection using this kit was
1 pg/ml. Some samples from each group (CRL and F2)
at each age (prepubertal and pubertal females, adult
males) were run in duplicate, but many samples did not
have sufficient serum to do this. Of those samples that
were run in duplicate (8 samples total), the coefficient of
variation ranged from 12 to 26.8%. For the calculation of
average serum 17β-estradiol concentrations, animals
with concentrations below the limit of detection were
assigned a value of 0.1 pg/ml.
Statistics
All experiments and measurements were conducted by
experimenters that were blind to treatment group. Data
were analyzed using SPSS version 23 (IBM Analytics,
Armonk NY). For comparisons of CRL versus F2
animals in each age group, independent samples T-tests
were used. An a priori p-value of 0.05 was selected for
statistical significance. All data displayed in graphs
represent mean ± SEM. Sample sizes for analyses are
indicated in Table 1.
Results
The male mammary gland is morphologically distinct in
two adult populations of CD-1 mice
This project was initiated after we made observations
suggesting that control, untreated male CD-1 mice from
commercially available sources had larger epithelial trees
than have been measured in untreated male CD-1 mice
in previous studies [29]. To characterize and quantify
the mammary gland morphology from CRL and F2 male
mice, we evaluated two growth parameters in each
Table 1 Sample sizes evaluated in this study
CRL (Population 1) F2 (Population 2)
Adult males 22 16
Prepubertal females 15 24
Pubertal females 20 22
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gland: ductal area and number of branching points. For
both parameters, the CRL animals were significantly
more developed (Fig. 1a and b). Correlative analyses sug-
gested that both populations displayed strong associa-
tions between the number of branching points and
ductal area (Fig. 1c), consistent with observations that
larger glands are also more elaborated (e.g. have more
individual ducts). In the CRL males, the R2 value is
0.9119 (p < 0.001) and in the F2 males, the R2 value is
0.8382 (p < 0.001). However, statistical comparisons of
these linear regressions did not reveal statistically signifi-
cant responses between the responses observed in the
CRL and F2 males (ANOVA, p = 0.106). Collectively,
these results suggest that the CRL and F2 males are
morphologically distinct because the CRL males have
larger, more highly branched mammary glands com-
pared to the F2 males, but that the relationship between
ductal area and branching points is indistinguishable
between CRL and F2 males.
The number and size of TEBs are different between two
pre-pubertal populations of CD-1 female mice
We next examined mammary gland morphology in CRL
and F2 females at PND24. This period of time was se-
lected because it is prior to the onset of first proestrus
and most animals do not yet display vaginal opening,
two measures that are indicative of the onset of puberty
[34, 35]. The area subtended by ducts was very similar
between these two groups, but the number and density
of TEBs was significantly lower in the CRL females com-
pared to the F2 females (Fig. 2a and b and data not
shown). Average size of TEBs was similar between the
two groups (Fig. 2b). Using regression analysis, both
populations displayed positive associations between
ductal area and number of TEBs, suggesting that larger
glands are also more developed (Fig. 2c). This association
was only significant in the F2 females [CRL females, R2 =
0.1996, p = 0.095; F2 females, R2 = 0.4254, p < 0.001]. Statis-
tical comparisons of these linear regressions did not reveal
Fig. 1 The mammary gland is larger and more developed in CRL adult males. a Representative whole mount mammary glands from F2 and CRL
males. Scale bar = 1 mm. b Quantification of two parameters of the male mammary gland, ductal area (left) and number of branching points
(right) reveals significant differences between F2 and CRL males. For both graphs, * indicates p≤ 0.01. c Linear regression analyses reveal strong
associations between the number of branching points and ductal area in both F2 and CRL males, but CRL males had more branching points per
square millimeter of ductal area than F2 males
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statistically significant differences between the relationship
between ductal area and TEBs observed in the CRL and F2
females at prepuberty (ANOVA, p = 0.154). Taken collect-
ively, these results suggest subtle but statistically significant
differences between CRL and F2 females in prepuberty;
these modest changes in morphology may be too slight to
easily differentiate these populations.
Several morphological features distinguish CRL and F2
females at puberty
The third group of animals we evaluated included CRL
and F2 females collected on PND35, after the onset of
puberty. At this age, mammary glands from CRL females
were significantly smaller compared to F2 females, with
ductal areas approximately half as large (Fig. 3a and b).
Total TEB number, TEB density and average TEB size
were also significantly different between these groups,
with more TEBs in the F2 females and a higher density
and average TEB size in the CRL females (Fig. 3b and
data not shown). We also observed differences in the
density of the mammary epithelium in F2 and CRL
pubertal females. The F2 females had significantly denser
epithelium in the region adjacent to the nipple and in
the entire ductal tree, but not in the lateral areas closest
to the lymph node (Table 2). These results are consistent
with increased amounts of internal branches and buds in
the F2 females.
Strikingly, when we evaluated the relationship between
ductal area and number of TEBs using linear regression
analysis, there was a statistically significant, positive asso-
ciation in the CRL animals (R2 = 0.3337, p < 0.01), but a
null - or slightly negative - association in the F2 group that
was not statistically significant (R2 = 0.0483, p = 0.493)
(Fig. 3c). Comparing these linear regressions revealed the
possibility that CRL and F2 females respond differently
because there was a trend toward statistically significant
differences between the responses observed in the CRL
and F2 females at puberty (ANOVA, p = 0.075). Import-
antly, the relationship between ductal area and the
number of TEBs appeared to be biphasic (non-mono-
tonic) in the F2 pubertal females. A polynomial
regression [order = 2] was a better fit for these data
Fig. 2 CRL females have fewer TEBs compared to F2 females at PND24. a Representative whole mount mammary glands from F2 and CRL
females at PND24. Scale bar = 1 mm. Examples of TEBs are indicated by red arrows. b Quantification of three parameters of the female mammary
gland, ductal area (left), number of TEBs (middle), and average TEB size (right). CRL females had fewer TEBs but no differences in TEB size or ductal
area compared to F2 females. *, p < 0.05. c Linear regression analyses reveal positive associations between ductal area and number of TEBs in
both F2 and CRL females. F2 females typically had more TEBs per square millimeter of ductal area compared to CRL females
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(R2 = 0.2562, p < 0.05, Fig. 3c). Together, these results
suggest that these two mouse populations have differ-
ent mammary gland appearances that allow them to
be distinguishable.
Serum estradiol concentrations do not distinguish CRL
and F2 animals
To determine whether the differences in mammary gland
development could be attributed to differences in circulat-
ing concentrations of 17β-estradiol, the hormone that
drives ductal growth and TEB development, we evaluated
serum concentrations of 17β-estradiol in adult males, pre-
pubertal females, and pubertal females from the CRL and
F2 groups. The detection rate was below 0.5 in all groups
except the CRL males; no samples had concentrations
above the limit of detection in CRL females at pre-puberty
or puberty (Fig. 4a). When we compared concentrations
in F2 and CRL animals, there were no significant differ-
ences in any of the groups (Fig. 4b). Collectively, these re-
sults suggest that serum concentrations of 17β-estradiol
are not sufficient to distinguish populations of mice that
have morphologically distinct mammary glands.
Fig. 3 CRL females have smaller mammary glands with more dense TEBs at puberty. a Representative whole mount mammary glands from F2
and CRL females at puberty. Scale bar = 1 mm. Examples of TEBs are indicated by red arrows. b Quantification of three parameters of the female
mammary gland, ductal area (left), number of TEBs (middle), and average TEB size (right). CRL females had smaller ductal trees, and fewer but larger
TEBs compared to F2 females. *, p < 0.02. C) Linear regression analyses reveal positive associations between ductal area and number of TEBs in CRL
females. However, there was little association between ductal area and number of TEBs in F2 females. For this reason, a polynomial regression was also
performed (see dotted line), and this provided a much better fit for the CRL pubertal female data
Table 2 Epithelial density in CRL and F2 females at puberty
CRL (Population 1) F2 (Population 2) p-value (independent samples t-test)
Nipple region 0.518 ± 0.025 0.617 ± 0.027 p = 0.010
Lateral to lymph node 0.580 ± 0.026 0.639 ± 0.034 p = 0.178
Whole ductal tree 0.572 ± 0.015 0.660 ± 0.022 p = 0.002
Data provided represent means ± SEM, intensity is a unitless measure
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Discussion
Our initial observations of male CRL mammary glands
were that these glands were larger than expected, con-
sistent with developmental exposures to EDCs like BPA
[29]. In fact, the mammary glands collected from CRL
animals were most similar to CD-1 male mice from
prior studies that were developmentally exposed to BPA
in the range of 2.5 – 25 μg/kg/day [29]. Further quan-
tifications revealed that our F2 animals, raised in con-
trolled conditions with concerted efforts to limit EDC
exposures, display small ductal trees similar to what
have been reported previously in other controlled envi-
ronments [29–31, 36].
At first glance, the female data show that mammary
glands from CRL females are smaller at puberty, which
might be interpreted as suggesting that their chemical
exposures are lower than those experienced in the F2
females. However, studies examining the effects of BPA
on the pubertal mammary gland have shown that lower
doses can increase ductal area whereas higher doses can
decrease ductal area [35, 37]. These studies also demon-
strate that BPA doses in the ng/kg and μg/kg range can
significantly shift the density of TEBs in the mammary
gland, to produce densities consistent with what we have
observed in the CRL females. Thus, it is highly likely
that all of the CRL animals experienced developmental
exposures to xenoestrogens.
Is it possible that the CRL and F2 animals have some
other feature that distinguishes these two populations,
e.g. could our observations be due to genetic drift? Non-
environmental differences between CRL and F2 animals
seem highly unlikely, especially considering that all of
our F2 animals were derived from animals that were or-
dered from the commercial supplier (e.g. F2 animals are
only two generations removed from CRL animals), and
it is unexpected that such drastic genetic changes could
occur in just two generations of controlled breeding.
However, our study is limited because we do not know
what chemicals CRL animals might have been exposed
to during development or the specific source of chemical
exposures. Although our results are both qualitatively
and quantitatively consistent with exposures to BPA in
the low dose range [38], similar effects on the mammary
gland are expected from exposures to other xenoestrogens
including common chemical contaminants in animal feed,
phytoestrogens, or other compounds that might leach
from plastics used in cages, water bottles, or other housing
devices [39–41]. Furthermore, our studies suggest that
commercial laboratories are raising animals in environ-
ments that are not well defined when it comes to EDC ex-
posures. We expect that these exposures are low enough
that they are not affecting fertility or fecundity, as com-
mercial animal suppliers are acutely aware of these health
outcomes; our results here suggest that xenoestrogen
exposures in vendor laboratories that have modest (or per-
haps no) effect on reproductive outcomes could still influ-
ence other hormone-sensitive endpoints including the
mammary gland.
It is theoretically possible to determine what chemicals
the CRL animals were exposed to during early develop-
ment. First, some chemicals with longer half-lives may
still be present in the blood of these animals at the time
of necropsy, or additional animals could be sacrificed
immediately upon arrival for the collection of blood and
tissues. It is important to note that collecting serum for
these purposes can be difficult because of the potential
for contamination, the requirement for large volumes of
serum to do broad screening rather than measures for
single compounds, and concerns that the most relevant
exposures likely occurred during embryonic and fetal
development and thus may no longer be present in the
Fig. 4 Serum 17β-estradiol levels are similar between F2 and CRL
animals. a An ELISA kit with a limit of detection of 1 pg/ml was used.
Detection rates ranged from 0 to 0.6 in each group. No significant differ-
ences in detection rate were observed for F2 and CRL animals in each
sex/age group. b Serum 17β-estradiol levels were highest in adult males,
but were also variable. Significant differences in serum concentrations
were not observed between F2 and CRL animals for any sex/age group.
Sample sizes for ELISA were n= 6 F2 males, n= 5 CRL males, n= 6 F2
prepubertal females, n= 5 CRL prepubertal females, n= 6 F2 pubertal
females, n= 5 CRL pubertal females
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blood of animals that are weeks or months old [42–44].
Recent studies have shown that novel metabolomics
methods can reveal persistent changes in metabolic
“fingerprints” including variations in glucose, amino
acids, and neurotransmitters in the serum of animals
exposed to BPA during early development [45]. Altered
metabolomic profiles were maintained for at least
180 days after exposures ceased [46]. These studies sug-
gest the possibility that features of an animals’ serum
could be used to not only determine what compound(s)
they were exposed to, but also what dose. However,
until such metabolomics profiles are available for the
most common environmental contaminants, their use
in the retrospective determination of chemical expo-
sures will remain very limited.
Certainly, a priori screening of items in the animal
facility is the best approach to avoid environmental
chemical contamination of animals to be used in la-
boratory experiments. However, the ability to perform
a posteriori evaluations to determine whether inad-
vertent contamination has occurred remains important,
especially when new materials are introduced in animal
care settings without the knowledge of the experimenter.
In these cases, post hoc evaluative approaches using meta-
bolomics are very resource intensive and require extensive
training in sensitive molecular biology techniques. In con-
trast, analysis of mammary gland morphology is straight-
forward and inexpensive. For this reason, the tools we
have demonstrated in this manuscript may prove to be
sufficient to distinguish populations with distinct environ-
mental histories that include chemical exposures during
vulnerable periods of development.
There are two important consequences of our findings
which are consistent with low-level xenoestrogen contam-
ination in commercially available animals. The first arises
from the use of adult animals for toxicity screening of
environmental chemicals. If an experimental protocol re-
quires that adult animals be exposed to test compounds,
developmental exposures to EDC mixtures could interfere
with the accuracy of this testing. There are a number of
studies that have demonstrated that early life exposure to
BPA alters responsiveness of animals to hormones or car-
cinogen challenges at puberty or in adulthood [35, 47–52].
This “two hit” model suggests that, for some endpoints,
developmental exposures may not be sufficient to induce
adverse effects, but the consequences of EDC exposures
are best seen when a secondary challenge is experienced
[22]. In this case, the uncontrolled EDC exposures that
occur in commercial animal facilities could represent “hit
one” and the controlled exposure experienced during tox-
icity testing would actually be “hit two”.
The second concern related to uncontrolled EDC
exposures is the use of historical controls in toxicity
testing in commercial laboratories. In some testing
protocols, when the negative controls have unexpected re-
sponses, experimenters will instead use “historical
controls”, e.g. unexposed controls collected in previous
experiments, including experiments that may have been
conducted years prior [53]. A report from the Historical
Control Working Group from the Society of Toxicologic
Pathology noted that “[s]tudy design-related parameters
such as laboratory, species/strain, route of administration,
vehicle, feed, feeding practices, study duration, and hous-
ing have a potential to impact study outcomes and control
findings. These parameters should be considered when
selecting the appropriate studies” to generate historical
control data [54]. Yet, differences in background EDC ex-
posures may occur even when experimenters think they
are following the guidance of this working group. Other
groups have highlighted differences in endocrine end-
points in historical controls from different testing facilities
used to evaluate chemicals for endocrine disrupting ac-
tivities [55, 56], suggesting that this issue may be more
widespread than the single commercial laboratory we
examined. Our results suggest that ‘control’ animals
may not be unexposed; thus, using historical controls
which might have one set of background EDC expo-
sures to compare to experimental animals with an
entirely different environmental history should not be
acceptable practice [11].
Conclusions
Here, we compared mammary gland morphologies for
two “control” populations with distinct environmental
histories and found significant differences in adult males,
prepubertal females, and pubertal females. These results
suggest that the mammary gland may be a sensitive
organ to probe populations for unknown environmental
EDC exposures during vulnerable periods of develop-
ment. Our results also dispute the use of historical
controls because environmental EDC exposures may
differ between experiments due to changes in cages,
water bottles, animal feed, water, or other environmental
factors that might otherwise appear benign.
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